Bio Decontamination Market Set to Boom: Strategic Insights and Growth Opportunities with Key Players; Cherwell Laboratories, Fedegari Autoclavi S.p.A., JCE Biotechnology
The global bio-decontamination
market is projected to expand at approximately 6% by 2026.
Growth is being driven by a rising volume of surgical procedures, increasing
rates of hospital-acquired infections (HAIs), the worldwide expansion of the
pharmaceutical and biotechnology sectors, greater demand for
bio-decontamination to prevent bacterial and viral infections, a higher level
of outsourcing for related services, and the adoption of stricter medical
hygiene regulations.
Download Sample Copy: https://meditechinsights.com/bio-decontamination-market/request-sample/
Bio-decontamination refers to the removal or reduction of
microbiological contamination to a safe, acceptable level. It involves a
combination of cleaning, disinfection, and/or sterilization processes used to
ensure that reusable medical devices (e.g., surgical instruments) are safe for
subsequent use. All infectious materials and contaminated equipment must be
decontaminated before being washed, stored, or discarded. Regular
bio-decontamination is essential across multiple environments—including
healthcare facilities, research institutes, pharmaceutical and biotech sites,
and cleanrooms—to maintain best-practice hygiene and safety standards.
Increasing
Use of Bio-decontamination for Infection Prevention Is Driving Market Growth
Bacteria and microorganisms exist in virtually every
environment, with some pathogenic species posing significant risks to human
health. Hospital-acquired infections (HAIs) affect approximately one in every
25 hospitalized patients. To curb the transmission of harmful microorganisms,
facilities increasingly rely on cleaning, bio-decontamination, and other
hygiene control measures. In laboratories, cleanrooms, and sterile
environments, room decontamination is considered one of the most effective
methods for reducing disease transmission risks.
Market growth is also fueled by the introduction of
advanced bio-decontamination technologies and products aimed at improving
infection prevention.
Examples include:
- September 2021: STERIS launched the next generation of integrated
Vaporized Hydrogen Peroxide (VHP) systems—VHP 100i and 1000i—designed to
integrate with building automation and HVAC systems and operate
decontamination cycles automatically or on demand.
- August 2021: TOMI Environmental Solutions Inc. introduced SteraPak,
powered by iHP technology, offering a high-performance, cost-effective
alternative to electrostatic sprayers that have faced safety-related
recalls.
A leading U.S.-based chief researcher noted:
“Growing usage of advanced technologies is expected to drive the market. For
instance, modern technologies such as ultraviolet light, ionization products,
hydrogen peroxide vapor, and room decontamination methods have been very
effective in reducing bacterial contamination.”
Impact
of COVID-19 on the Bio-decontamination Market
The COVID-19 pandemic significantly increased global
demand for bio-decontamination solutions across hospitals, pharmaceutical and
medical device manufacturers, and life sciences and biotechnology research
organizations. Temporary treatment facilities and high-touch surfaces such as
beds, medical devices, and equipment required frequent decontamination to
reduce HAIs. Additionally, bio-decontamination services played a critical role
in converting COVID-19 wards back to standard-use facilities, further
amplifying market demand during the pandemic.
Download Sample Copy: https://meditechinsights.com/bio-decontamination-market/request-sample/
Regional
Insights: North America Leads the Market
North America represents the largest share of the
global bio-decontamination market, followed by Europe and the Asia-Pacific
region. The region’s dominance is attributed to a high volume of surgical
procedures, stringent government regulations, rising HAI prevalence, and the
presence of major industry players. APAC is expected to experience substantial
growth driven by increasing awareness of hygiene, rising HAI rates, and
expanding pharmaceutical and medical device manufacturing.
Competitive
Landscape
Key companies operating in the global
bio-decontamination market include:
Cherwell Laboratories, Fedegari Autoclavi S.p.A., JCE
Biotechnology, STERIS plc, Howorth Air Technology Limited, Bioquell (Ecolab),
TOMI Environmental Solutions Inc., ClorDiSys Solutions Inc., Noxilizer,
Solidfog Technologies SPRL, Zhejiang Tailin Bioengineering Co. Ltd., Vaisala,
Scanbur A/S, Amira S.r.l., Tecomak, DIOP GmbH, and A.M. Instruments S.r.l.,
among others.
Growth
Strategies: Organic and Inorganic Expansion
To strengthen their market presence, companies are
pursuing strategies such as collaborations, acquisitions, and new product developments.
Recent examples:
- May 2022: Bio-decontamination startup Delox secured
$751,000 in seed funding led by Kiilto Ventures, bringing its total raised
capital to over $1.3 million, supporting commercialization efforts.
- September 2021: STERIS entered a strategic partnership with H+E
Pharma to design, install, and maintain turnkey clean utility water
systems for pharmaceutical and biotechnology applications in Europe.
Full Research Report here: https://meditechinsights.com/bio-decontamination-market/
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business
research & insights firm. Our clients include Fortune 500 companies,
blue-chip investors & hyper-growth start-ups. We have completed 100+
projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices
& Pharma Services in the areas of market assessments, due diligence,
competitive intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research
combined with deep-dive interviews with industry-leading CXO, VPs, and key
demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
Comments
Post a Comment